date:Jul 12, 2012
Lots that are determined to meet specific standards will be made available as required. At this time, the information needed from Sanofi to complete the evaluation process for unreleased lots of ImmuCyst has not yet been provided to the Department.
Health Canada has also requested that Sanofi communicate directly with Canadian health care practitioners as soon as possible, to advise them of the situation.
Patients taking ImmuCyst should speak with their health care provider if they have concern